Yıl: 2019 Cilt: 8 Sayı: 4 Sayfa Aralığı: 967 - 970 Metin Dili: İngilizce DOI: doi: 10.5455/medscience.2019.08.9061 İndeks Tarihi: 23-11-2020

Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis

Öz:
Allergic Rhinitis is basically a chronic disease that decreases quality of life. Antihistaminics have been used for the first time in allergic rhinitis. In the search for an alternative treatment in resistant allergic rhinitis, Montelukasts and their combinations have been used. Randomized double-blind controlled study. In our study, the effect on the quality of life of the compounds used recently be compared after 3 months of treatment. In this study, 7 groups of 40 patients, 18-65 years old were planned for each group. The number of females and males was equal in each group (20). The patients in group A and group B will be called for checks after 3 months of medical treatment in the C-D-E-F-G-H group without treatment for 3 months. The patients in Group C received 10 mg Rupatadin Fumarate tablets orally (1 * 1 single dose) before bedtime, 5 mg Levosetirizine Dihydrochloride tablets in the patients in Group D orally (1 * 1 single dose) before bedtime, 10 mg Montelukast Sodium tablets in patients in Group E Before oral (1 * 1 single dose), patients in Group F 5 mg Desloratadin + 10 mg Montelukast Sodium tablets orally (1 * 1 single dose) before bedtime, and patients in Group G Levocetirizine Dihydrochloride + 10 mg Montelukast Sodium tablet orally before bedtime (1 * 1 single dose) will be given. These treatments will continue for 3 months without interruption. The Rinokonjucivations Quality of Life Questionnaire (RQLQ) will be completed with a total of 28 questions. No significant superiority of the Rupatadine molecule to levocetirizine was detected. The score of the Montelukast areas was significantly low when compared to the Rupatadine and Levosetirizine groups. Combined Montelukastes were found to be much more effective than single antihistaminics and single montelukast. There was no difference in quality of life between the combined Montelukast. Antihistaminics are the first treatment option in patients with allergic rhinitis,In resistant cases, combinations with montelukast should be used.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. Acta Allergol. 2000;55:116-34.
  • Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1997;8:161-76.
  • Cingi C, Oghan F, Eskiizmir G, et al. Desloratadine-montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2013;801-6.
  • Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol. 1997;99:742-9.
  • Izquierdo I, Merlos M, García-Rafanell J. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. Drugs Today (Barc). 2003;39:451-68.
  • Leynadier F, Mees K, Arendt C, et al. Efficacy and safety of levocetirizine in seasonal allergic rhinitis. Acta Otorhinolaryngol Belg. 2001;55:305-12.
  • Okuda M, Watase T, Mezawa A, et al. The role of leukotriene D4 in allergic rhinitis. Ann Allergy. 1988;60:537-40.
  • Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebocontrolled clinical trial. J Allergy Clin Immunol. 2000;105:917-22.
  • Nayak AS, Philip G, Lu S, et al. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol.2002;88:592-600.
  • 10. Philip G, Malmstrom K, Hampel FC, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy. 2002;32:1020-8.
  • 11. Patel P, Philip G, Yang W, et al. Randomized, double-blind, placebo controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2005;95:551-7.
  • 12. Jiang RS. Efficacy of a leukotriene receptor antagonist in the treatment of perennial allergic rhinitis. J Otolaryngol. 2006;35:117-21.
  • 13. Cingi C, Ozlugedik S. Effects of montelukast on quality of life in patients with persistent allergic rhinitis. Otolaryngol Head Neck Surg. 2010;142:654–58.
  • 14. Ciebiada M, Gorska-Ciebiada M, Barylski M, et al. Use of montelukast alone or in combinationwith desloratadine or levocetirizine in patients with persistent allergic rhinitis. Am J Rhinol Allergy. 2011;25:1–6.
  • 15. Ciebiada M, Ciebiada MG, Kmiecik T, et al. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. J Investig Allergol Clin Immunol. 2008;18:343-9.
  • 16. Greiner AN, Hellings PW, Rotiroti G, et al. Allergic rhinitis. Lancet. 2011;378:2112-22.
  • 17. Brożek, J, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol Pract. 2018;140:950-8.
  • 18. Wang, H, Lee JC, Wu PC, et al . Effects of montelukast on human nasal mucosa. Eur Arch Otorhinolaryngol. 2019;276:761-5.
  • 19. Chen H, Lou H, Wang Y, et al. Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis. Int Forum Allergy Rhinol. 2018;124252.
  • 20. Kim MK, Lee SY, Park HS, et al. A Randomized, multicenter, doubleblind, phase ııı study to evaluate the efficacy on allergic rhinitis and safety of a combination therapy of montelukast and levocetirizine in patients with asthma and allergic rhinitis. J Eng Sci Med Diagn Ther. 2018;40:1096-107.
  • 21. Imoto Y. Takabayashi T, Sakashita M, et al. Combination therapy with montelukast and loratadine alleviates pharyngolaryngeal symptoms related to seasonal allergic rhinitis. J Allergy Clin Immunol Pract. 2019;7:1068-70
  • 22. Wei C. The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: a systematic review and meta-analysis. Biomed Pharmacother. 2016;83:989-99.
  • 23. Li L, Wang R, Cui L, et al. Efficacy of montelukast as prophylactic treatment for seasonal allergic rhinitis. Ear Nose Throat J. 2018;97:12-6.
  • 24. Kaur G, Dhingra R, Singh M. comparative study to assess clinical efficacy of leukotriene receptor antagonist and antihistamines in the treatment of allergic rhinitis. Bengal J Otolaryngol Head Neck Surg. 2017;25:81-8.
  • 25. Cingi C, Gunhan K, Gage WL, et al. Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis. Laryngoscope. 2010;120:1718-23.
  • 26. Mahatme MS, Dakhale GN1, Tadke K, et al. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukastfexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial. Indian J Pharmacol. 2016:48:649-53.
  • 27. Jullaphant T, Nakpeng T, Srichana T. Montelukast nasal spray: formulation development and in vitro evaluation. Pharm Dev Technol. 2019;24:494-503.
APA YILDIZ E, KOCA YILDIZ D, Ulu Ş, KOCA T (2019). Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. , 967 - 970. doi: 10.5455/medscience.2019.08.9061
Chicago YILDIZ Erkan,KOCA YILDIZ DUDU SELCEN,Ulu Şahin,KOCA Tulay Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. (2019): 967 - 970. doi: 10.5455/medscience.2019.08.9061
MLA YILDIZ Erkan,KOCA YILDIZ DUDU SELCEN,Ulu Şahin,KOCA Tulay Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. , 2019, ss.967 - 970. doi: 10.5455/medscience.2019.08.9061
AMA YILDIZ E,KOCA YILDIZ D,Ulu Ş,KOCA T Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. . 2019; 967 - 970. doi: 10.5455/medscience.2019.08.9061
Vancouver YILDIZ E,KOCA YILDIZ D,Ulu Ş,KOCA T Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. . 2019; 967 - 970. doi: 10.5455/medscience.2019.08.9061
IEEE YILDIZ E,KOCA YILDIZ D,Ulu Ş,KOCA T "Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis." , ss.967 - 970, 2019. doi: 10.5455/medscience.2019.08.9061
ISNAD YILDIZ, Erkan vd. "Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis". (2019), 967-970. https://doi.org/doi: 10.5455/medscience.2019.08.9061
APA YILDIZ E, KOCA YILDIZ D, Ulu Ş, KOCA T (2019). Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. Medicine Science, 8(4), 967 - 970. doi: 10.5455/medscience.2019.08.9061
Chicago YILDIZ Erkan,KOCA YILDIZ DUDU SELCEN,Ulu Şahin,KOCA Tulay Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. Medicine Science 8, no.4 (2019): 967 - 970. doi: 10.5455/medscience.2019.08.9061
MLA YILDIZ Erkan,KOCA YILDIZ DUDU SELCEN,Ulu Şahin,KOCA Tulay Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. Medicine Science, vol.8, no.4, 2019, ss.967 - 970. doi: 10.5455/medscience.2019.08.9061
AMA YILDIZ E,KOCA YILDIZ D,Ulu Ş,KOCA T Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. Medicine Science. 2019; 8(4): 967 - 970. doi: 10.5455/medscience.2019.08.9061
Vancouver YILDIZ E,KOCA YILDIZ D,Ulu Ş,KOCA T Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis. Medicine Science. 2019; 8(4): 967 - 970. doi: 10.5455/medscience.2019.08.9061
IEEE YILDIZ E,KOCA YILDIZ D,Ulu Ş,KOCA T "Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis." Medicine Science, 8, ss.967 - 970, 2019. doi: 10.5455/medscience.2019.08.9061
ISNAD YILDIZ, Erkan vd. "Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis". Medicine Science 8/4 (2019), 967-970. https://doi.org/doi: 10.5455/medscience.2019.08.9061